ACVR1 and fibrodysplasia ossificans progressiva: In animal models of FOP, blocking Activin A signaling with monoclonal antibodies or small compounds has been demonstrated to decrease HO [54]. BMPs are ligands that bind to ACVR1 and regulate bone formation.